Not found

Dan Peer, PhD

Full Affiliate Member, Research Institute
Houston Methodist


A tissue chamber chip for assessing nanoparticle mobility in the extravascular space
Lusi, V, Moore, TL, Laurino, F, Coclite, A, Perreira, R, Ferreira, M, Rizzuti, I, Palomba, R, Zunino, P, Duocastella, M, Mizrahy, S, Peer, D & Decuzzi, P 2019, Biomedical Microdevices, vol. 21, no. 2, 41.

Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D, Joshi, N, Tao, W, Karp, JM & Peer, D 2018, Nature communications, vol. 9, no. 1, 1410.

Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes
Veiga, N, Goldsmith, M, Granot, Y, Rosenblum, D, Dammes, N, Kedmi, R, Ramishetti, S & Peer, D 2018, Nature Communications, vol. 9, no. 1, 4493.

Quantitative analysis of recombinant glucocerebrosidase brain delivery via lipid nanoparticles
Goldsmith, M, Abramovitz, L, Braunstein, H, Horowitz, M & Peer, D 2018, Nano Futures, vol. 2, no. 4, 045003.

Gene Silencing in the Right Place at the Right Time
Guktin, A & Peer, D 2018, Molecular Therapy, vol. 26, no. 11, pp. 2539-2541.

A modular platform for targeted RNAi therapeutics
Kedmi, R, Veiga, N, Ramishetti, S, Goldsmith, M, Rosenblum, D, Dammes, N, Hazan-Halevy, I, Nahary, L, Leviatan-Ben-Arye, S, Harlev, M, Behlke, M, Benhar, I, Lieberman, J & Peer, D 2018, Nature Nanotechnology, pp. 1-6.

Focus on RNA interference: From nanoformulations to in vivo delivery
Karp, JM & Peer, D 2018, Nanotechnology, vol. 29, no. 1, 010201.

Hierarchical theranostic nanomedicine: MRI contrast agents as a physical vehicle anchor for high drug loading and triggered on-demand delivery
Liu, G, Deng, J, Liu, F, Wang, Z, Peer, D & Zhao, Y 2018, Journal of Materials Chemistry B, vol. 6, no. 13, pp. 1995-2003.

Targeting central nervous system pathologies with nanomedicines
Mizrahy, S, Gutkin, A, Decuzzi, P & Peer, D 2018, Journal of Drug Targeting.

Personalized Hydrogels for Engineering Diverse Fully Autologous Tissue Implants
Edri, R, Gal, I, Noor, N, Harel, T, Fleischer, S, Adadi, N, Green, O, Shabat, D, Heller, L, Shapira, A, Gat-Viks, I, Peer, D & Dvir, T 2018, Advanced Materials.

Engineering lymphocytes with RNAi
Ramishetti, S & Peer, D 2018, Advanced Drug Delivery Reviews.

Next-Generation Lipids in RNA Interference Therapeutics
Rietwyk, S & Peer, D 2017, ACS Nano, vol. 11, no. 8, pp. 7572-7586.

Emerging Trends in Micro- and Nanoscale Technologies in Medicine: From Basic Discoveries to Translation
Alvarez, MM, Aizenberg, J, Analoui, M, Andrews, AM, Bisker, G, Boyden, ES, Kamm, RD, Karp, JM, Mooney, DJ, Oklu, R, Peer, D, Stolzoff, M, Strano, MS, Trujillo-De Santiago, G, Webster, TJ, Weiss, PS & Khademhosseini, A 2017, ACS Nano, vol. 11, no. 6, pp. 5195-5214.

Comprehensive and Systematic Analysis of the Immunocompatibility of Polyelectrolyte Capsules
Zyuzin, MV, Díez, P, Goldsmith, M, Carregal-Romero, S, Teodosio, C, Rejman, J, Feliu, N, Escudero, A, Almendral, MJ, Linne, U, Peer, D, Fuentes, M & Parak, WJ 2017, Bioconjugate Chemistry, vol. 28, no. 2, pp. 556-564.

Advanced strategies in immune modulation of cancer using lipid-based nanoparticles
Mizrahy, S, Hazan-Halevy, I, Landesman-Milo, D, Ng, BD & Peer, D 2017, Frontiers in Immunology, vol. 8, no. FEB, 69.

Drug Delivery Research for the Future: Expanding the Nano Horizons and Beyond
Mitragotri, S, Lammers, T, Bae, YH, Schwendeman, S, De Smedt, S, Leroux, JC, Peer, D, Kwon, IC, Harashima, H, Kikuchi, A, Oh, YK, Torchilin, V, Hennink, W, Hanes, J & Park, K 2017, Journal of Controlled Release, vol. 246, pp. 183-184.

Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions
Anchordoquy, TJ, Barenholz, Y, Boraschi, D, Chorny, M, Decuzzi, P, Dobrovolskaia, MA, Farhangrazi, ZS, Farrell, D, Gabizon, A, Ghandehari, H, Godin, B, La-Beck, NM, Ljubimova, J, Moghimi, SM, Pagliaro, L, Park, JH, Peer, D, Ruoslahti, E, Serkova, NJ & Simberg, D 2017, ACS Nano, vol. 11, no. 1, pp. 12-18.

Orchestrating a Symphony on a Single Conjugate: Aptamer Targeting, Gene Silencing, and Immunomodulation to Enhance Antitumor Response
Ng, BD & Peer, D 2017, Molecular Therapy, vol. 25, no. 1, pp. 5-7.

Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes
Mizrahy, S, Hazan-Halevy, I, Dammes, N, Landesman-Milo, D & Peer, D 2017, Molecular Therapy.

Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics-An innate immune system standpoint
Granot, Y & Peer, D 2017, Seminars in Immunology.

Live Chat Available